Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.3390/v13020270

http://scihub22266oqcxt.onion/10.3390/v13020270
suck pdf from google scholar
33572452!7916233!33572452
unlimited free pdf from europmc33572452    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid33572452      Viruses 2021 ; 13 (2): ä
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Synthetic Messenger RNA-Based Vaccines: from Scorn to Hype #MMPMID33572452
  • Pascolo S
  • Viruses 2021[Feb]; 13 (2): ä PMID33572452show ga
  • In the race for a vaccine against SARS-CoV-2, the synthetic mRNA format has been shown to be the fastest one and proved to be safe and highly efficient, even at the very low dose of a few microg per injection. The mRNA vaccines are not new: vaccines that are based on attenuated mRNA viruses, such as Mumps, Measles, and Rubella, immunize by delivering their mRNAs into the cells of the vaccinated individual, who produces the viral proteins that then prime the immune response. Synthetic mRNA in liposomes can be seen as a modern, more refined, and thereby a safer version of those live attenuated RNA viruses. The anti-COVID-19 mRNA vaccine (coding the SARS-CoV-2 spike protein) is the third synthetic RNA therapeutic being approved. It follows the aptamer Macugen((R)) (which neutralizes VEGF) and the siRNA Onpattro((R)) (which destroys the transthyretin-coding mRNA). Remarkably, the 30 microg of mRNA that are contained in the first approved anti-COVID-19 vaccine are sufficient for generating high levels of neutralizing antibodies against the virus in all injected volunteers (including participants over 65 years old). The efficacy and safety data are stunning. The distribution of these vaccines throughout the world will bring a halt to the coronavirus pandemic.
  • |Animals[MESH]
  • |Antibodies, Neutralizing/immunology[MESH]
  • |Antibodies, Viral/immunology[MESH]
  • |COVID-19 Vaccines/administration & dosage/adverse effects/genetics/*immunology[MESH]
  • |COVID-19/*prevention & control[MESH]
  • |Humans[MESH]
  • |Pandemics[MESH]
  • |SARS-CoV-2/genetics/*immunology[MESH]
  • |Spike Glycoprotein, Coronavirus/genetics/immunology[MESH]
  • |Vaccines, Synthetic/administration & dosage/adverse effects/genetics/*immunology[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box